Literature DB >> 24131174

Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes.

Lauri Vehkala1, Olavi Ukkola, Y Antero Kesäniemi, Mika Kähönen, Markku S Nieminen, Veikko Salomaa, Antti Jula, Sohvi Hörkkö.   

Abstract

AIM: Obesity and type 2 diabetes (T2D) associate with increased oxidative stress. Malondialdehyde acetaldehyde (MAA) adducts have been suggested to be one of the antigenic epitopes in MDA-LDL responsible for the antibody recognition. Our aim was to investigate the associations between plasma IgA antibodies to MAA-LDL, inflammatory markers, adipokines, obesity, and T2D.
METHODS: IgA to MAA-LDL were measured in a subsample (n = 1507) of the Finnish Health 2000 survey. The associations between antibody levels, obesity, TNF-α, IL-6, high-sensitivity (hs) CRP, resistin, adiponectin, fasting plasma (fp) glucose, fp-insulin, glycosylated hemoglobin (Hb-A1C), and T2D were investigated.
RESULTS: IgA to MAA-LDL associated positively with fasting plasma insulin. IgA to MAA-LDL were higher among subjects with T2D (P < 0.001) compared to subjects with normal glucose metabolism. IgA to MAA-LDL associated with obesity, but was not independently (P = 0.002, not significant after correction for multiple tests) associated with T2D in logistic regression analysis. IgA to MAA-LDL, obesity, and TNF-α all associated with markers of glucose metabolism.
CONCLUSIONS: T2D subjects had increased IgA to MAA-LDL compared to subjects with normal glucose metabolism. The data suggest that the associations between IgA to MAA-LDL and markers of glucose metabolism were independent of TNF-α but dependent on components of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24131174     DOI: 10.3109/07853890.2013.841322

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  10 in total

1.  Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients.

Authors:  Aulikki Kononoff; Pia Elfving; Pirkko Pussinen; Sohvi Hörkkö; Hannu Kautiainen; Leena Arstila; Leena Laasonen; Elina Savolainen; Helena Niinisalo; Jarno Rutanen; Olga Marjoniemi; Mari Hämäläinen; Katriina Vuolteenaho; Eeva Moilanen; Oili Kaipiainen-Seppänen
Journal:  Ann Med       Date:  2020-02-10       Impact factor: 4.709

2.  Accumulation of acetaldehyde in aldh2.1-/- zebrafish causes increased retinal angiogenesis and impaired glucose metabolism.

Authors:  David Philipp Wohlfart; Bowen Lou; Chiara Simone Middel; Jakob Morgenstern; Thomas Fleming; Carsten Sticht; Ingrid Hausser; Rüdiger Hell; Hans-Peter Hammes; Julia Szendrödi; Peter Paul Nawroth; Jens Kroll
Journal:  Redox Biol       Date:  2022-01-26       Impact factor: 11.799

Review 3.  Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis.

Authors:  Maria Isabel Trejo-Zambrano; Eduardo Gómez-Bañuelos; Felipe Andrade
Journal:  Antioxid Redox Signal       Date:  2021-06-04       Impact factor: 7.468

4.  Impact of Diabetes on the Gut and Salivary IgA Microbiomes.

Authors:  Eric L Brown; Heather T Essigmann; Kristi L Hoffman; Noah W Palm; Sarah M Gunter; Joel M Sederstrom; Joseph F Petrosino; Goo Jun; David Aguilar; William B Perkison; Craig L Hanis; Herbert L DuPont
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.609

5.  Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy.

Authors:  Satu Vavuli; Tuire Salonurmi; Sirpa Loukovaara; Antti E Nissinen; Markku J Savolainen; M Johanna Liinamaa
Journal:  J Diabetes Res       Date:  2016-12-20       Impact factor: 4.011

6.  The impact of the Th17:Treg axis on the IgA-Biome across the glycemic spectrum.

Authors:  Heather T Essigmann; Kristi L Hoffman; Joseph F Petrosino; Goo Jun; David Aguilar; Craig L Hanis; Herbert L DuPont; Eric L Brown
Journal:  PLoS One       Date:  2021-10-20       Impact factor: 3.240

7.  Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis.

Authors:  Hannah E Lomzenski; Geoffrey M Thiele; Michael J Duryee; Sheau-Chiann Chen; Fei Ye; Daniel R Anderson; Ted R Mikuls; Michelle J Ormseth
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

8.  Association of inflammatory sialoproteins, lipid peroxides and serum magnesium levels with cardiometabolic risk factors in obese children of South Indian population.

Authors:  G Niranjan; D Anitha; A R Srinivasan; V Kuzhandai Velu; C Venkatesh; M Sathish Babu; R Ramesh; S Saha
Journal:  Int J Biomed Sci       Date:  2014-06

9.  Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease.

Authors:  Daniel R Anderson; Michael J Duryee; Scott W Shurmur; John Y Um; Walter D Bussey; Carlos D Hunter; Robert P Garvin; Harlan R Sayles; Ted R Mikuls; Lynell W Klassen; Geoffrey M Thiele
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

10.  Evidence that endogenous formaldehyde produces immunogenic and atherogenic adduct epitopes.

Authors:  Jun Nakamura; Takasumi Shimomoto; Leonard B Collins; Darcy W Holley; Zhenfa Zhang; Jenna M Barbee; Vyom Sharma; Xu Tian; Tomohiro Kondo; Koji Uchida; Xianwen Yi; Diana O Perkins; Monte S Willis; Avram Gold; Scott J Bultman
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.